Home / Market News / $AHCO
fiscal.ai Corporate Catalyst Impact 85/100 ● negative

AdaptHealth Corp. Reports Third Quarter 2026 Financial Results

Nov 3, 2026, 2:06 PM UTC · Primary ticker $AHCO

AdaptHealth reported Q3 2026 revenue exceeding consensus, but a significant net loss due to a large goodwill write-down. The company also updated its full-year revenue guidance and provided updates on strategic initiatives, indicating mixed financial performance with ongoing operational adjustments.

AdaptHealth reported Q3 2026 revenue of $745.6 million, surpassing the FactSet consensus of $725.9 million, which is a positive signal for top-line growth. However, the company posted a substantial net loss of $168.2 million, primarily driven by a $184.8 million pre-tax goodwill write-down. This write-down indicates potential impairment of past acquisitions or assets, raising concerns about asset valuation and future profitability. Adjusted EBITDA also saw a slight decline year-over-year. The updated full-year 2026 revenue guidance of $2.88 billion to $2.90 billion provides a clearer outlook for investors. The progress on the capitated partnership and the impending sale of the Diabetes Health business suggest strategic realignments, which could be positive long-term but introduce short-term uncertainty. Traders should weigh the revenue beat against the significant net loss and goodwill impairment, which could pressure the stock in the short term, while strategic divestitures might offer long-term value creation.

$AHCO negative Net loss due to goodwill write-down
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.